TY - JOUR
T1 - Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis
T2 - A systematic review and meta-analysis
AU - Fairley, Jessica L.
AU - Ross, Laura
AU - Quinlivan, Alannah
AU - Hansen, Dylan
AU - Paratz, Elizabeth
AU - Stevens, Wendy
AU - Kistler, Peter M.
AU - McLellan, Alex
AU - La Gerche, Andre
AU - Nikpour, Mandana
N1 - Funding Information:
JLF holds a NHMRC Postgraduate Scholarship (GNT2013842) and an Australian Government Research Training Program Scholarship . LR holds an Arthritis Australia – ARA Victoria Fellowship. MN holds an NHMRC Emerging Leadership Investigator Grant ( GNT1176538 ). PK holds an NHMRC Leadership Investigator Grant ( APP 2018163 ). EP holds a University of Melbourne Senior Research Fellowship. ALG holds a National Heart Foundation of Australia Future leadership fellowship and an NHMRC Career Development Fellowship.
Funding Information:
JLF holds a NHMRC Postgraduate Scholarship (GNT2013842) and an Australian Government Research Training Program Scholarship. LR holds an Arthritis Australia – ARA Victoria Fellowship. MN holds an NHMRC Emerging Leadership Investigator Grant (GNT1176538). PK holds an NHMRC Leadership Investigator Grant (APP 2018163). EP holds a University of Melbourne Senior Research Fellowship. ALG holds a National Heart Foundation of Australia Future leadership fellowship and an NHMRC Career Development Fellowship.
Publisher Copyright:
© 2023
PY - 2023/10
Y1 - 2023/10
N2 - Objective: To calculate the frequency of sudden cardiac death(SCD), arrhythmia and conduction defects in SSc. Methods: MEDLINE/EMBASE were searched to January 2023. English-language studies reporting the incidence/frequency of SCD, arrhythmia and electrocardiography(ECG) abnormalities in SSc were included. Odds ratios(OR), estimations of annual incidence or pooled frequencies were calculated. Results: Seventy-nine studies(n = 13,609 participants with SSc) were included in the meta-analysis. Methodology and outcomes were heterogeneous. Ten studies included cohorts with known/suspected SSc-associated heart involvement(SHI), generally defined as clinically-manifest cardiac disease/abnormal cardiac investigations. The incidence of SCD in SHI was estimated to be 3.3% annually(n = 4 studies, 301PY follow-up). On ambulatory ECG, 18% of SHI cohorts had non-sustained ventricular tachycardia(NSVT; n = 4, 95%CI3.2–39.3%), 70% frequent premature ventricular complexes (PVCs; n = 1, 95%CI34.8–93.3%), and 8% atrial fibrillation (AF; n = 1, 95%CI4.2–13.6%). Nineteen studies included participants without SHI, defined as normal cardiac investigations/absence of cardiac disease. The estimated incidence of SCD was approximately 2.9% annually (n = 1, 67.5PY). Compared to healthy controls, individuals without SHI demonstrated NSVT 13.3-times more frequently (n = 2, 95%CI2–102), and paroxysmal supraventricular tachycardia 7-times more frequently (n = 4, 95%CI3–15). Other ambulatory ECG abnormalities included NSVT in 9% (n = 7, 95%CI6–14%), >1000 PVCs/24 h in 6% (n = 2, 95%CI1–13%), and AF in 7% (n = 5, 0–21%). Fifty studies included general SSc cohorts unselected for cardiac disease. The incidence of SCD was estimated to be 2.0% annually(n = 4 studies, 1646PY). Unselected SSc cohorts were 10.5-times more likely to demonstrate frequent PVCs (n = 2, 95%CI 2–59) and 2.5-times more likely to have an abnormal electrocardiography (n = 2, 95%CI1–4). Conclusions: The incidence of SCD in SSc is estimated to be 1.0–3.3% annually, at least 10-fold higher than general population estimates. Arrhythmias including NSVT and frequent PVCs appear common, including amongst those without known/suspected SHI.
AB - Objective: To calculate the frequency of sudden cardiac death(SCD), arrhythmia and conduction defects in SSc. Methods: MEDLINE/EMBASE were searched to January 2023. English-language studies reporting the incidence/frequency of SCD, arrhythmia and electrocardiography(ECG) abnormalities in SSc were included. Odds ratios(OR), estimations of annual incidence or pooled frequencies were calculated. Results: Seventy-nine studies(n = 13,609 participants with SSc) were included in the meta-analysis. Methodology and outcomes were heterogeneous. Ten studies included cohorts with known/suspected SSc-associated heart involvement(SHI), generally defined as clinically-manifest cardiac disease/abnormal cardiac investigations. The incidence of SCD in SHI was estimated to be 3.3% annually(n = 4 studies, 301PY follow-up). On ambulatory ECG, 18% of SHI cohorts had non-sustained ventricular tachycardia(NSVT; n = 4, 95%CI3.2–39.3%), 70% frequent premature ventricular complexes (PVCs; n = 1, 95%CI34.8–93.3%), and 8% atrial fibrillation (AF; n = 1, 95%CI4.2–13.6%). Nineteen studies included participants without SHI, defined as normal cardiac investigations/absence of cardiac disease. The estimated incidence of SCD was approximately 2.9% annually (n = 1, 67.5PY). Compared to healthy controls, individuals without SHI demonstrated NSVT 13.3-times more frequently (n = 2, 95%CI2–102), and paroxysmal supraventricular tachycardia 7-times more frequently (n = 4, 95%CI3–15). Other ambulatory ECG abnormalities included NSVT in 9% (n = 7, 95%CI6–14%), >1000 PVCs/24 h in 6% (n = 2, 95%CI1–13%), and AF in 7% (n = 5, 0–21%). Fifty studies included general SSc cohorts unselected for cardiac disease. The incidence of SCD was estimated to be 2.0% annually(n = 4 studies, 1646PY). Unselected SSc cohorts were 10.5-times more likely to demonstrate frequent PVCs (n = 2, 95%CI 2–59) and 2.5-times more likely to have an abnormal electrocardiography (n = 2, 95%CI1–4). Conclusions: The incidence of SCD in SSc is estimated to be 1.0–3.3% annually, at least 10-fold higher than general population estimates. Arrhythmias including NSVT and frequent PVCs appear common, including amongst those without known/suspected SHI.
KW - Arrhythmia
KW - Conduction block
KW - Sudden cardiac death
KW - Systemic sclerosis
UR - http://www.scopus.com/inward/record.url?scp=85169292445&partnerID=8YFLogxK
U2 - 10.1016/j.semarthrit.2023.152229
DO - 10.1016/j.semarthrit.2023.152229
M3 - Review Article
C2 - 37354723
AN - SCOPUS:85169292445
SN - 0049-0172
VL - 62
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
M1 - 152229
ER -